
1. General Information
Abirapro 250 mg Tablet is an oral oncology medicine containing abiraterone acetate, a selective CYP17 inhibitor. It reduces the production of androgens (male sex hormones), which can contribute to the growth of prostate cancer cells.
It is a prescription medicine and should be used only under the supervision of an oncologist or other qualified healthcare professional. Abiraterone therapy is normally given as part of a broader treatment regimen rather than as a standalone medicine.
2. Product Information
| Product | Abirapro 250 mg Tablet |
|---|---|
| Active ingredient | Abiraterone acetate |
| Strength | 250 mg |
| Drug class | Androgen biosynthesis inhibitor / CYP17 inhibitor |
| Dosage form | Oral tablet |
| Therapeutic area | Oncology |
| Main therapeutic area | Advanced prostate cancer |
| Prescription status | Prescription medicine |
The 250 mg strength is also available as a formulation of abiraterone acetate; treatment regimens may require multiple tablets to achieve the prescribed daily dose.
3. Uses of Abirapro 250 mg
Abiraterone acetate is used as part of treatment for certain patients with advanced or metastatic prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC) and certain high-risk metastatic castration-sensitive prostate cancer (mCSPC) settings.
The exact treatment combination depends on the patient's diagnosis, previous treatment, disease status and physician's assessment.
4. Benefits of Abirapro 250 mg
Potential therapeutic benefits include:
- Helps reduce androgen production in the body.
- Helps suppress hormonal stimulation of prostate cancer cells.
- Can be incorporated into treatment regimens for advanced/metastatic prostate cancer.
- Provides an oral treatment option for appropriate patients.
- May be used alongside corticosteroid therapy and androgen-deprivation treatment according to the prescribed regimen.
Important: It is not appropriate to describe Abirapro as a cure for prostate cancer. Its benefits depend on the patient's cancer type and overall treatment plan.
5. Side Effects of Abirapro 250 mg
Abiraterone can cause adverse effects because it changes steroid-hormone production and may increase mineralocorticoid activity.
Important potential adverse effects include:
- High blood pressure
- Low potassium levels
- Fluid retention or swelling
- Liver-function abnormalities
- Fatigue
- Joint pain
- Nausea
- Diarrhea
- Vomiting
- Hot flushes
- Headache
Serious liver toxicity can occur, so liver-function monitoring is important during treatment.
6. Common Side Effects
Commonly reported adverse reactions include:
- Fatigue
- Joint pain (arthralgia)
- Hypertension
- Nausea
- Edema/swelling
- Hypokalemia
- Hot flush
- Diarrhea
- Vomiting
- Upper respiratory infection
- Cough
- Headache
Changes in laboratory tests such as anemia, increased alkaline phosphatase, increased blood glucose, abnormal lipid levels and low potassium may also occur.
7. How to Use Abirapro 250 mg
Take Abirapro exactly as prescribed by the treating physician.
For the standard abiraterone regimen, the medicine is taken once daily on an empty stomach. The FDA labeling specifies that food should be avoided around the dose because food can substantially change abiraterone exposure. Tablets should be swallowed whole with water and should not be crushed or chewed.
The prescribed dose can differ according to the patient's condition, liver function and treatment regimen. Do not change the dose yourself.
8. How Abirapro Works
Abiraterone acetate works by inhibiting CYP17, an enzyme involved in androgen biosynthesis.
By blocking this pathway, abiraterone decreases androgen production in the testes, adrenal glands and prostate-tumor tissue. Lower androgen levels can reduce hormonal stimulation of prostate cancer cells.
Because CYP17 inhibition can also alter corticosteroid and mineralocorticoid pathways, abiraterone is generally administered with a corticosteroid and requires appropriate monitoring.
9. Safety Advice
Liver: Liver function should be monitored. Abiraterone can cause serious hepatotoxicity, and treatment may need to be interrupted or discontinued if significant liver abnormalities occur.
Blood pressure and potassium: Blood pressure, potassium levels and signs of fluid retention should be monitored because mineralocorticoid excess can occur.
Heart conditions: Patients with cardiovascular disease require particular caution and medical monitoring.
Diabetes: Abiraterone treatment can be associated with hypoglycemia in certain patients taking particular diabetes medicines, so glucose monitoring may be necessary.
Liver impairment: Abiraterone requires special consideration in patients with hepatic impairment and is not recommended in patients with severe baseline hepatic impairment according to the cited FDA labeling.
Pregnancy: Abiraterone can cause fetal harm. Appropriate contraceptive precautions are required for patients with partners who could become pregnant, according to prescribing guidance.
Interactions: Tell the doctor about all prescription medicines, OTC medicines and supplements being taken. Abiraterone has clinically important drug-interaction considerations, including CYP3A4 inducers and certain CYP2D6 substrates.
10. Frequently Asked Questions
Q1. What is Abirapro 250 mg Tablet?
Abirapro 250 mg contains abiraterone acetate, an androgen-biosynthesis inhibitor used in specific prostate-cancer treatment settings.
Q2. What is Abirapro 250 mg used for?
It is used as part of treatment for certain advanced or metastatic prostate cancers.
Q3. Is Abirapro a chemotherapy medicine?
It is not conventional cytotoxic chemotherapy. It is a hormonal/androgen-biosynthesis targeted treatment that inhibits CYP17.
Q4. Does Abirapro need to be taken with food?
No. Standard abiraterone tablets are taken on an empty stomach because food can significantly alter drug exposure.
Q5. Is Abirapro usually taken with prednisone?
Yes. Abiraterone is generally used with a corticosteroid such as prednisone/prednisolone according to the physician's prescribed regimen.
Q6. Can I take Abirapro without consulting a doctor?
No. It is a prescription oncology medicine requiring appropriate diagnosis, dosing and monitoring.
Q7. What monitoring is required?
Depending on the treatment plan, doctors may monitor liver function, blood pressure, potassium, fluid retention and other relevant laboratory parameters.
Q8. Can Abirapro cure prostate cancer?
It should not be marketed or described as a guaranteed cure. Its role is to help control specific forms of advanced prostate cancer as part of an individualized treatment plan.
11. Substitute for Abirapro 250 mg
Possible alternatives depend on the patient's cancer type, treatment stage, previous medicines and physician's treatment strategy. Medicines containing abiraterone acetate may be considered equivalent only when the strength, formulation, quality and regulatory status are appropriate.
Other prostate-cancer medicines—including different androgen-receptor pathway inhibitors—are not automatically interchangeable with Abirapro.
Examples of medicines in the broader treatment category include abiraterone acetate products, enzalutamide, apalutamide and darolutamide, but they have different indications, mechanisms, dosing and safety profiles. A doctor should determine the appropriate alternative.
12. SEO & B2B Keywords
For Phoenix Exim's product catalog, you can use keywords such as:
- Abirapro 250 mg Tablet exporter from India
- Abiraterone acetate 250 mg Tablet supplier India
- Abirapro 250 mg pharmaceutical exporter
- Abiraterone acetate tablets exporter from Nagpur
- Abirapro 250 mg medicine supplier India
- Abiraterone acetate 250 mg wholesale supplier
- Abirapro 250 mg tablets international supplier
- Abiraterone acetate pharmaceutical distributor India
- Abirapro 250 mg tablets for prostate cancer treatment
- Abiraterone acetate 250 mg oncology medicine supplier
- Abirapro 250 mg exporter to USA
- Abirapro 250 mg exporter to UK
- Abirapro 250 mg exporter to Australia
- Abirapro 250 mg exporter to Singapore
- Abirapro 250 mg exporter to Canada
- Abirapro 250 mg exporter to South Korea
- Abirapro 250 mg exporter to UAE
- Abiraterone acetate supplier for international buyers
- Abirapro 250 mg B2B pharmaceutical supplier
- Abiraterone acetate oncology medicine exporter India
- Abirapro 250 mg prostate cancer medicine supplier
- Abiraterone acetate tablets wholesale exporter
- Abirapro 250 mg trusted pharma exporter India
- Abiraterone acetate medicine exporter from Nagpur India
- Abirapro 250 mg pharmaceutical trading supplier
- Abiraterone acetate 250 mg bulk medicine supplier
- Abirapro 250 mg international pharmaceutical exporter
- Abiraterone acetate 250 mg B2B medicine supplier
- Abirapro 250 mg India pharmaceutical supplier
- Phoenix Exim Abirapro 250 mg exporter
Keywords







